TRINETRA · The third eye on the Indian stock market

Outlook — the week and month ahead, from measured factors

Every factor on this page cites a written benchmark result. The market regime, breadth and institutional flow pillars come from the live engine; the seasonality is derived from 4,683 NIFTY bars rather than imported from a US seasonal map — March / fiscal-year-end carries a +1.888% edge over the unconditional 20-day return with a 70.3% win rate, while January and February are the weakest months at −1.72% and −2.06%.

The dated calendar — weekly and monthly F&O expiry, the Union Budget, fiscal-year boundaries and advance-tax instalments — is fact, not forecast, and where a window has a measured seasonal character it is shown alongside.

The page carries no index up-or-down call, and says so. No factor tested here forecasts index direction, and what this page does not know is listed as prominently as what it does — including a Gann time rule that passed on the index and was retracted after a per-stock test showed its edge was a selection artifact.

Explore TRINETRA

TRINETRA — the third eye on the Indian stock market — Rule-based NSE stock screener for Indian traders: daily breakout scans, Weinstein Stage 2 leaders, sector rotation, Darvas boxes, IPO radar and results calendar.
The Daily Edge — today's NSE breakout scan — Today's full-universe NSE scan: breakout setups and Stage 2 leaders graded with entry pivot, structural stop and reasoning. Updated 9:30 AM and 2:20 PM IST.
Weekly Report — what we flagged and what happened next — A transparent weekly scorecard: every stock TRINETRA flagged and how it moved over the next 7 and 14 trading days — target hit, stop hit or still open.
Sector rotation — which NSE sectors lead and which lag — Which Indian sectors are leading or lagging today: NSE sector and broad indices ranked by returns, relative strength vs Nifty 50, Weinstein stage and RRG quadrant.
Trinetra Vishwa — the global-macro read on India — How global macro is likely to hit Indian stocks today: one two-sided verdict on crude, dollar, yields and global indices, with plain-English drivers and F&O positioning.
Watchlist — NSE stocks close to a breakout pivot — Stocks setting up for a breakout, tiered from the last full NSE scan — Priority 1, Priority 2 and Getting Ready — with the pivot each must cross.
Darvas box breakout scanner for NSE stocks — Darvas box breakouts on NSE, date by date: which stocks broke out of their box, which are still coiling, and the exact box top each must cross.
Results calendar — earnings dates and the market's reaction — Upcoming and recent quarterly results for NSE companies, with how the stock price reacted after each announcement, sector by sector.
IPO Radar — recent NSE listings and how they've performed — Recent mainboard IPOs on NSE: listing-day gains and how each new listing has performed since — sorted by newest, listing pop or return since listing.
The Eye — market breadth, smart-money flows and the full scan — NSE market breadth, FII and DII cash flows, and the full graded cross-section of the daily stock scan with filters for RS, Stage 2 and fresh triggers.
How TRINETRA works — the rule ladder behind every grade — The exact rule ladder behind TRINETRA's stock grades: Weinstein stage analysis, relative strength, Darvas boxes, Wyckoff and VPA volume rules, Livermore pivots and structural stops.
Astro — real sidereal astronomy, with every claim scored — Sidereal (Vedic) astronomy computed to arcminutes — pañcāṅga, graha positions, Vimśottarī daśā, retrogrades, eclipse seasons and yoga detection — with the measured hit-rate of every factor against 41 years of NIFTY, gold, crude, Bitcoin and S&P 500 data. 7,560 cells tested; none showed a tradeable edge.
Fundamentals — what the filings actually say — Quarterly financials from NSE filings for Indian equities: revenue and profit growth, net and EBITDA margins, cost structure, effective tax rate, interest coverage and sector peer percentiles — with the as-of date on every number and an explicit list of what cannot be computed.

TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing.